Shares of Arch Therapeutics, Inc. (OTCMKTS:ARTH – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.21 and traded as low as $0.19. Arch Therapeutics shares last traded at $0.19, with a volume of 100 shares.
Arch Therapeutics Stock Down 10.7 %
The business has a fifty day moving average price of $0.21 and a 200 day moving average price of $0.27.
Arch Therapeutics Company Profile
Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.
Read More
- Five stocks we like better than Arch Therapeutics
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for Arch Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
